Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
NCT02503631 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 397
Last updated 2018-04-06
Summary
The primary objective of this study is to obtain de-identified, clinically characterized, stool and plasma specimens for use in assessing new markers for the detection of neoplasms of the digestive tract.
Conditions
- Colorectal Neoplasms
- Digestive System Diseases
- Colonic Diseases
- Colorectal Cancer
Interventions
- DEVICE
-
Stool Sample Collection Kit
Stool sample collection kit
Sponsors & Collaborators
-
Exact Sciences Corporation
lead INDUSTRY
Principal Investigators
-
Michael Domanico · Exact Sciences
Eligibility
- Min Age
- 40 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2017-03-31
- Completion
- 2017-09-30
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Evaluation of a Point-of-care Testing Instrument for Fecal Immunochemical Test
NCT05232721 ·Status: UNKNOWN
-
Point of Care, Real-Time Urine Metabolomics Test to Diagnose Colorectal Cancers and Polyps in Low-and Middle-Income Countries
NCT05679960 ·Status: SUSPENDED ·Phase: NA
-
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
NCT03821948 ·Status: COMPLETED
-
Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for CRC Screening
NCT04693546 ·Status: SUSPENDED
-
Screening Tests in Detecting Colorectal Cancer
NCT00025025 ·Status: COMPLETED
-
Colorectal Cancer Screening Validation Study
NCT00720993 ·Status: UNKNOWN
-
CRC Detection Reliable Assessment With Blood
NCT05551052 ·Status: ACTIVE_NOT_RECRUITING
-
Plasma-based Colorectal Cancer Screening Research & Development
NCT04027790 ·Status: COMPLETED
-
Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing
NCT01741363 ·Status: COMPLETED ·Phase: NA
-
Colon Cancer Study of Fecal Samples in Shanghai, China
NCT01778595 ·Status: COMPLETED
-
Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma
NCT01511653 ·Status: COMPLETED
-
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial
NCT03765736 ·Status: TERMINATED
-
Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer
NCT00102011 ·Status: COMPLETED ·Phase: PHASE3
-
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
NCT00899626 ·Status: RECRUITING
-
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
NCT03728348 ·Status: COMPLETED
-
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
NCT02503696 ·Status: COMPLETED
-
Molecular Stethoscope
NCT02578264 ·Status: COMPLETED
-
Interventions to Improve Colorectal Cancer Screening
NCT00692211 ·Status: COMPLETED ·Phase: NA
-
Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer
NCT05115786 ·Status: UNKNOWN
-
Clinical Validation of Stool DNA-based SDC2 Methylation Test for Colorectal Cancer Detection
NCT03146520 ·Status: COMPLETED
-
Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
NCT00617071 ·Status: UNKNOWN ·Phase: PHASE3
-
Reproducibility of a Fecal Occult Blood Test Device for Gut Microbiota Analyses
NCT01194687 ·Status: COMPLETED
-
Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer
NCT03476122 ·Status: UNKNOWN
-
Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers
NCT03563651 ·Status: COMPLETED
-
GI SPORE Colon Biosample Protocol
NCT02243267 ·Status: COMPLETED